MedTrix Healthcare partners with top 3 Pharma companies in emerging markets

The partnership is expected to provide patient engagement as an enterprise-wide solution with the ability to integrate several therapy areas in the emerging markets

0
733

MedTrix Healthcare, a provider of digital and medical communication solutions to top Pharma companies globally, has announced that it has partnered with one of the top 3 Pharma companies in emerging markets to provide patient engagement as an enterprise-wide solution with the ability to integrate several therapy areas. The patient engagement activity is an effort from global Pharma to improve the way it communicates with patients and offer services in line with patient centricity.

This is a multi-specialty program capable of integrating several brands and therapies using a single platform. The platform offers modular care plans, pill reminders, disease education and provides better patient access to caregivers. This is available as mobile app using IoS and Android platforms for patients along with a web dashboard for the administrators or program owners.

The Global Pharmaceutical Industry is at an inflection point, where it is pivoting from doing Digital to being Digital. The key aspect to this shift is the growing pressure on global pharma in terms of cost, ability to innovate, emergence of technology and the usage of the digital medium to reach their customers and patients. We have the expertise to fulfil the technical and scientific requirements for this natural progression. At MedTrix we combine science, technology and strategy with our ISO certified systems and processes to accomplish specific business objectives for our clients” said Mr Vimal Narayanan, Founder and Director, MedTrix Healthcare.

“We are among the rarest breed of companies who are able to work in the strategic digital & medical communication space for our clients. For most of our clients, we are the first company from India or elsewhere to provide the kind of solutions that we offer. We are planning to expand our existing presence in multiple geographies including US, Europe and Asia Pacific regions by increasing our access into the top 20 Pharma Companies”, added Vimal Narayanan.